Dr. Saunders has received speaking fees (less than $10,000 each) from Wyeth, Merck, Sharp, & Dohme. Dr. Porter has received consulting and speaking fees (less than $10,000 each) from Abbott, Roche, and Bristol-Myers Squibb, and consulting fees (less than $10,000) from Wyeth.
Rheumatoid Arthritis Clinical Studies
You have full text access to this OnlineOpen article
Triple therapy in early active rheumatoid arthritis: A randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies†
Article first published online: 25 APR 2008
DOI: 10.1002/art.23449
Copyright © 2008 by the American College of Rheumatology
Additional Information
How to Cite
Saunders, S. A., Capell, H. A., Stirling, A., Vallance, R., Kincaid, W., McMahon, A. D. and Porter, D. R. (2008), Triple therapy in early active rheumatoid arthritis: A randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis & Rheumatism, 58: 1310–1317. doi: 10.1002/art.23449
- †
EudraCT database no. 2004-002006-30.
Publication History
- Issue published online: 25 APR 2008
- Article first published online: 25 APR 2008
- Manuscript Accepted: 1 FEB 2008
- Manuscript Received: 24 JUL 2007
Funded by
- Chief Scientist Office of the Scottish Executive
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Muscle disorders * 111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study, Rheumatology, 2012, 51, suppl 3, iii93
- 2, , , , , , What is meant by active disease in the NICE recommendation on use of combination therapy in early RA?, Rheumatology, 2012, 51, 5, 947
- 3, , Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence, Clinical Investigation, 2011, 1, 4, 557
- 4, , , , , , , Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial, Rheumatology, 2011, 51, 4, 686
- 5, , , , Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors  and  : correlation with methotrexate efficacy in rheumatoid arthritis patients, Rheumatology, 2011, 50, 9, 1665
- 6, , , , Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice, Clinical Rheumatology, 2011, 31, 1, 163
- 7, Rheumatoid arthritis: When should we use rituximab to treat RA?, Nature Reviews Rheumatology, 2011, 7, 7, 379
- 8, , Treatment of Early Rheumatoid Arthritis: Concepts in Management, Seminars in Arthritis and Rheumatism, 2011, 40, 5, 371
- 9, , , , , , , , , , , , , , , BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy, Rheumatology, 2010,
- 10, , Impact of tight control strategy on rheumatoid arthritis in Sarawak, Clinical Rheumatology, 2010, 30, 5, 615
- 11, , , , , , Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome, Rheumatology, 2010, 49, 11, 2154
- 12, , New understanding and approaches to treatment in rheumatoid arthritis, British Medical Bulletin, 2010, 94, 1, 201
- 13, , Optimising the strategy of care in early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2010, 24, 4, 443
- 14, , , , , , , , , Qualität einer interdisziplinären Sprechstunde in der Rheumaorthopädie, Zeitschrift für Rheumatologie, 2010, 69, 8, 749
- 15, , , , , , , , RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): Agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds, Arthritis Care & Research, 2010, 62, 2Direct Link:
- 16, , Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis, Current Opinion in Rheumatology, 2010, 22, 3, 316
- 17, , Ups and downs in the treatment strategies of rheumatoid arthritis, Rheumatology, 2010, 50, 5, 818
- 18
- 19, , , A Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID3) Scores are Informative in Patients with All Rheumatic Diseases, Rheumatic Disease Clinics of North America, 2009, 35, 4, 819
- 20, , , , , , , Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS), Rheumatology, 2009, 48, 6, 650
- 21
- 22, , Clinical approaches to early inflammatory arthritis, Nature Reviews Rheumatology, 2009, 5, 11, 627
- 23, , , , , , , , , , Contemporary treatment principles for early rheumatoid arthritis: a consensus statement, Rheumatology, 2009, 48, 7, 765
- 24, , , , , The BeSt story: on strategy trials in rheumatoid arthritis, Current Opinion in Rheumatology, 2009, 21, 3, 291
- 25, What have we learnt about the development and progression of early RA from RCTs?, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 13
- 26, , Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement, Rheumatology, 2008, 47, 11, 1600

1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
